Primary Structure: Human ghrelin is a 28-amino acid peptide with a post-translational octanoyl modification on serine-3 (Ser³), essential for receptor activation .
Molecular Weight: 3,370.9 g/mol (unmodified) and 12.8 kDa for recombinant forms .
Derived from preproghrelin (117 amino acids), which is cleaved into proghrelin and further processed into active ghrelin and obestatin .
Post-translational acylation by ghrelin O-acyltransferase (GOAT) is critical for functional activity .
Recombinant human ghrelin (ProSpec Bio) contains 115 amino acids (residues 24–117) fused to a 20-amino acid His-tag, purified via chromatographic techniques .
Ghrelin activates the growth hormone secretagogue receptor 1a (GHS-R1a), a G protein-coupled receptor (GPCR) .
Key binding residues include E124³·³³, R283⁶·⁵⁵, and Q120³·²⁹, forming interactions with the octanoyl group .
Gq/11 Pathway: Mediates appetite stimulation and GH secretion .
Gi/o Pathway: Regulates insulin release inhibition and metabolic effects .
β-Arrestin Recruitment: Modulates receptor internalization and non-canonical signaling .
Appetite Stimulation: Circulating ghrelin peaks preprandially, enhancing hunger and foraging behavior .
Lipid/Glucose Metabolism: Modulates hepatic glucose output and adipogenesis .
Synergizes with GH-releasing hormone (GHRH) to amplify GH secretion from the pituitary .
Ghrelin-deficient mice show reduced GH pulsatility, particularly in females .
Cardioprotection: Reduces inflammation and promotes angiogenesis .
Immune Modulation: Suppresses pro-inflammatory cytokines (e.g., TNF-α) and enhances anti-inflammatory responses .
Neuroendocrine Effects: Influences stress responses via the hypothalamic-pituitary-adrenal (HPA) axis .
Ghrelin Agonists: Investigated for cachexia and GH deficiency .
Ghrelin Antagonists: Potential anti-obesity agents by blocking appetite signaling .
GHRL knockout mice exhibit sex-specific GH secretion deficits, highlighting hormonal dimorphism .
SNP rs696217 (Leu72Met) correlates with metabolic syndrome and cardiovascular risk .
Precision Therapeutics: Targeting ghrelin isoforms (e.g., des-acyl ghrelin) for metabolic disorders .
Immune Modulation: Exploiting ghrelin’s anti-inflammatory effects in autoimmune diseases .
The human preproghrelin gene (GHRL) is located on chromosome 3p25-26 and consists of five exons with four introns. The spliced ghrelin messenger RNA is translated to a 117-amino acid preproghrelin precursor, which is subsequently cleaved to yield the 28-amino acid ghrelin peptide. The name "ghrelin" derives from "ghre," a Proto-Indo-European root meaning "grow," referencing its ability to stimulate growth hormone release . Understanding this structure is essential for designing experiments that target specific domains of the molecule or its precursors.
Ghrelin serves multiple physiological functions in humans, primarily:
Stimulation of appetite and food intake
Regulation of growth hormone secretion
Influence on reward processing and hedonic aspects of feeding
Involvement in stress responses
Potential roles in neuropsychiatric conditions and substance use disorders
Research indicates that intravenous ghrelin administration enhances appetite in humans, with studies showing that after administration, subjects report vivid mental imagery of their preferred meals . Additionally, ghrelin appears to decrease sensitivity to negative feedback while increasing prediction-error related activity in the dorsal striatum, suggesting its involvement in reward processing extends beyond food-related rewards .
Ghrelin interacts with several key hormonal systems. When administered intravenously, ghrelin stimulates an immediate increase in plasma levels of:
Growth hormone (GH): from 35±16 ng/ml × min (placebo) to 2808±533 ng/ml × min (ghrelin); p<0.001
Cortisol: from 5908±984 ng/ml × min (placebo) to 10179±1293 ng/ml × min (ghrelin); p<0.001
ACTH: from 922±103 pg/ml × min (placebo) to 3030±763 pg/ml × min (ghrelin); p<0.02
Interestingly, leptin levels remain unchanged following ghrelin administration, suggesting leptin is not directly involved in ghrelin's acute effects on appetite stimulation .
Storage Time | Mean Ghrelin Concentration (pg/mL) | Standard Deviation |
---|---|---|
30 minutes (baseline) | 815.8044 | 563.92793 |
1 hour | 848.5118 | 558.86906 |
2 hours | 791.3658 | 515.57120 |
3 hours | 709.9261 | 440.04356 |
Statistical analysis revealed that while the 3-hour samples showed significant differences from the 30-minute (p=0.041), 1-hour (p=0.014), and 2-hour (p=0.063) samples, the 30-minute, 1-hour, and 2-hour samples did not significantly differ from each other . This suggests researchers may have more flexibility in sample processing time than previously thought, which is particularly valuable for clinical research settings where immediate processing may be challenging.
When designing human ghrelin studies, researchers must account for numerous factors that influence ghrelin levels:
Fasting status and recent food intake
Time of day (circadian variations)
Stress levels and emotional state
Physical activity prior to sampling
Body mass index and body composition
Age and sex differences
Medications, particularly those affecting metabolism or gastrointestinal function
A robust experimental design should incorporate standardized fasting periods (typically 8-12 hours), consistent timing of sample collection, detailed participant screening questionnaires, and appropriate statistical controls for factors like age, sex, and BMI. When using repeated measures designs, researchers should use correlation tests to identify multicollinear variables (r > 0.5, p < 0.01) and enter these separately into adjusted analyses .
Reversal learning tasks with monetary rewards provide an effective experimental paradigm for studying ghrelin's effects on reward processing. In a within-subject, double-blind, placebo-controlled design (n=30), intravenous ghrelin infusion decreased punishment sensitivity (t = −2.448, p = 0.021) while leaving reward sensitivity unchanged (t = 0.8, p = 0.43) .
Functional brain imaging during such tasks reveals increased prediction-error related activity in the dorsal striatum during ghrelin administration compared to placebo (t-values ≥ 4.21, p-values ≤ 0.044) . This experimental approach allows researchers to disentangle ghrelin's effects on positive and negative feedback processing while simultaneously measuring neural correlates.
The mechanism by which circulating ghrelin accesses the human brain remains incompletely understood, with conflicting results regarding its accessibility. This represents a significant research gap, as understanding these mechanisms is crucial for developing targeted therapies that modulate ghrelin's central effects .
Key methodological approaches to investigate this question include:
Blood-brain barrier permeability studies
Cerebrospinal fluid sampling before and after peripheral ghrelin administration
PET imaging with radiolabeled ghrelin analogs
Region-specific microdialysis in animal models
Researchers should also consider ghrelin's interactions with vagal afferents as an indirect pathway for peripheral ghrelin to influence central nervous system function.
Computational models derived from reward learning tasks provide valuable insights into ghrelin's behavioral effects. Parameters from these models help quantify specific aspects of reward processing, such as:
Punishment sensitivity
Reward sensitivity
Learning rates for positive and negative outcomes
Exploration vs. exploitation tendencies
Research employing such models demonstrates that ghrelin specifically decreases punishment sensitivity while leaving reward sensitivity intact . This computational approach offers advantages over simple behavioral measures by distinguishing between different components of reward processing and providing mechanistic insights into how ghrelin influences decision-making.
Sex differences represent an important variable in ghrelin research. Studies investigating ghrelin's effects on appetite and hormone secretion should include both male and female participants to assess potential sex-specific responses. One study examining ghrelin's effects on appetite included five women and four men, finding that appetite was enhanced in eight of nine subjects following ghrelin administration .
Researchers should consider:
Sex hormone interactions with the ghrelin system
Potential differences in ghrelin receptor expression
Sex-specific differences in neural responses to ghrelin
Variations in the appetitive and reward-processing effects of ghrelin between sexes
Statistical analyses should include sex as a variable, and studies should be adequately powered to detect sex-specific effects.
Contradictory findings in ghrelin research often stem from methodological differences. Researchers should systematically evaluate:
Sample collection and processing protocols
Assay methodologies (ELISA vs. RIA vs. mass spectrometry)
Active vs. total ghrelin measurements
Participant characteristics (BMI, age, health status)
Experimental conditions (fasting duration, time of day)
Dosing regimens in intervention studies
For example, the finding that blood samples stored for up to two hours show no significant differences in measured ghrelin concentrations compared to the recommended 30-minute protocol may explain inconsistencies between laboratory and clinical research, where strict adherence to the 30-minute protocol is often impractical.
Given the complex and often non-linear relationships in ghrelin research, sophisticated statistical approaches are recommended:
Repeated measures ANOVA for time-course studies, with appropriate tests for sphericity (e.g., Mauchly's test)
Post-hoc comparisons using Least Significant Difference or other appropriate tests
Multivariate analysis to control for confounding variables
Computational modeling to extract parameters representing specific cognitive processes
Region of interest analyses for neuroimaging data
Small sample sizes, common in human ghrelin research due to the intensive nature of the protocols, may warrant adjusting significance thresholds (e.g., p < 0.1 instead of p < 0.05) when using conservative post-hoc tests .
Disentangling ghrelin's cognitive effects from its metabolic effects requires careful experimental design. Research indicates that ghrelin influences both metabolic parameters and cognitive functions related to reward processing and food-seeking behavior.
Ghrelin administration affects glucose metabolism, potentially preventing marked decreases in glucose concentration that might otherwise occur . Simultaneously, ghrelin enhances appetite and stimulates vivid mental imagery of preferred meals , suggesting cognitive effects that may influence eating behavior beyond direct metabolic pathways.
Researchers should employ designs that control for or measure metabolic changes while assessing cognitive outcomes, using methods such as:
Euglycemic clamps to maintain stable glucose levels
Control conditions that match metabolic effects without cognitive effects
Mediation analyses to determine whether cognitive effects are dependent on metabolic changes
Emerging technologies offer promising avenues for advancing ghrelin research:
Single-cell RNA sequencing to identify cell populations responsive to ghrelin
CRISPR-based techniques to investigate ghrelin receptor function
Optogenetic and chemogenetic approaches in animal models to establish causal relationships
Advanced neuroimaging techniques to map ghrelin's effects on human brain function
Wearable sensors for continuous monitoring of physiological parameters related to ghrelin function
These approaches can help address fundamental questions about ghrelin's tissue-specific effects and temporal dynamics of action.
Ghrelin's involvement in reward processing suggests potential applications in:
Addictive disorders: Given ghrelin's role in reducing sensitivity to negative feedback and increasing prediction error-related striatal activity , it may influence risk-taking and impulsivity relevant to addiction
Stress-related disorders: Ghrelin's stimulation of cortisol and ACTH release suggests involvement in stress responses
Neuropsychiatric conditions: Animal and correlative human studies indicate ghrelin's potential role in mood regulation
Translational research should explore how ghrelin system modulation might address these conditions, using appropriate experimental paradigms that capture both metabolic and behavioral/cognitive outcomes.
Despite significant advances, several critical knowledge gaps remain:
The precise mechanisms by which ghrelin accesses the human brain remain incompletely characterized
The long-term effects of altered ghrelin signaling on neural circuits involved in reward processing
Interactions between ghrelin and other neuroendocrine systems in complex behavioral states
The role of ghrelin in developmental processes and potential programming effects
Individual differences in ghrelin sensitivity and their genetic/epigenetic determinants
Addressing these gaps requires interdisciplinary approaches combining molecular techniques, human experimental medicine, computational modeling, and longitudinal studies.
The human ghrelin gene (GHRL) is located on chromosome 3 and consists of multiple exons . The gene produces a 117-amino acid precursor protein called preproghrelin, which is further processed to produce the active 28-amino acid ghrelin peptide . Ghrelin becomes active when octanoic acid is linked to serine at the 3-position by the enzyme ghrelin O-acyltransferase (GOAT) .
Ghrelin has several important functions:
Human recombinant ghrelin is a synthetic form of the naturally occurring hormone, produced using recombinant DNA technology. This involves inserting the ghrelin gene into bacterial or yeast cells, which then produce the hormone. Recombinant ghrelin is used in research to study its effects and potential therapeutic applications.
Ghrelin has shown promise in various therapeutic areas: